FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, in particular, to molecular and clinical oncology. Described is a method for diagnosing ovarian cancer based on a group of genes of long non-coding RNA by detecting the methylation of at least one of three markers; according to the invention, the markers are the SSTR5-AS1, KCNK15-AS1, and MAGI2-AS3 genes.
EFFECT: claimed method allows for high clinical sensitivity and specificity in detecting ovarian cancer.
1 cl, 1 dwg, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF OVARIAN CANCER METASTASIS BASED ON SET OF GENES OF LONG NON-CODING RNA | 2023 |
|
RU2825782C1 |
| METHOD FOR PREDICTING BREAST CANCER METASTASIS BASED ON SET OF LONG NON-CODING RNA GENES | 2022 |
|
RU2807480C1 |
| METHOD FOR DIAGNOSING BREAST CANCER BASED ON A SET OF LONG NON-CODING RNA GENES | 2022 |
|
RU2795976C1 |
| METHOD FOR FORECASTING METASTASIS OF OVARIAN CANCER BASED ON MICRORNA GENE GROUP | 2016 |
|
RU2666911C2 |
| METHOD FOR DIAGNOSING OVARIAN CANCER BASED ON A GROUP OF microRNA GENES | 2018 |
|
RU2703399C1 |
| METHOD OF DIAGNOSIS OF CLEAR CELL RENAL CELL CARCINOMA AND METHOD FOR PREDICTION OF METASTASIS BASED ON MIRNA GENES GROUP | 2017 |
|
RU2683251C1 |
| METHODS OF CANCER SCREENING | 2012 |
|
RU2700088C2 |
| METHOD FOR ASSESSING THE RISK OF DEVELOPING LUNG CANCER AGAINST THE BACKGROUND OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2022 |
|
RU2790302C1 |
| METHOD FOR PREDICTING RECURRENCE OF SEROUS OVARIAN CARCINOMA | 2020 |
|
RU2749361C1 |
| SYSTEM OF MARKERS BASED ON GROUP OF MICRORNA GENES FOR DIAGNOSTICS OF NON-SMALL-CELL LUNG CANCER INCLUDING EPIDERMOID CANCER AND ADENOCARCINOMA | 2012 |
|
RU2507268C1 |
